← SynDRA
SARACATINIB
SynDRA canonical compound SYN0006380 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
| Primary target(s) | SRC |
| Mechanism of action | Src inhibitor |
All known targets
Mechanisms of action (all sources)
- SRC inhibitor
- ABL1 INHIBITOR
- Tyrosine-protein kinase ABL inhibitor
- Tyrosine-protein kinase SRC inhibitor
- LCK INHIBITOR
- YES1 INHIBITOR
- SRC MODULATOR
- ABL1 MODULATOR
Drug classes
- Antineoplastic Agents
- Enzyme Inhibitors
Cross-references
Synonyms
- AZD-0530
- AZ-10353926
- AZD0530
- H8H
- Saracatinib, AZD-0530, AZD0530
- N-(5-Chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine
- Saracatinib (AZD0530)
- AZD 0530
- N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine
- SARACATINIB, FREE BASE
- N-(5-chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine
- 9KD24QGH76
- CHEMBL217092
- N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine
- N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine
- 4-(6-Chloro-2,3-methylenedioxyanilino)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-tetrahydropyran-4-yloxyquinazoline
- 4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methyl-1-piperazinyl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)-
- Saracatinib [USAN]
- nchembio866-comp19
- Saracatinib [USAN:INN]
- saracatinibum
- UNII-9KD24QGH76
- 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
- 2h8h
- Saracatinib,AZD0530
- SARACATINIB [INN]
- Saracatinib (USAN/INN)
- Saracatinib - AZD0530
- SCHEMBL41547
- SARACATINIB [WHO-DD]
- MLS006011166
- GTPL7731
- BDBM12255
- CHEBI:47458
- AZD0350
- DTXSID90191355
- BCPP000364
- HMS3265E21
Look up SARACATINIB in the interactive SynDRA portal →